Renal Insufficiency as a Predictor of Adverse Events and Mortality after Renal Artery Stent Placement

American Journal of Kidney Diseases

Volumn 42, Issue 5, 2003, Pages 926-935

  Kennedy, David J ^b   Colyer, William R ^b   Brewster, Pamela S ^b   Ankenbrandt, Mary ^b   Burket, Mark W ^b   Nemeth, Attila S ^b   Khuder, Sadik A ^b   Thomas, William J ^b   Shapiro, Joseph I ^b   Cooper, Christopher J ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NONE

Author keywords

Adverse events; Mortality; Renal artery stenosis (RAS); Renal insufficiency (RI)

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CAUSE OF DEATH; COMORBIDITY; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ASSOCIATION; DRUG USE; FEMALE; HEART INFARCTION; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; RENOVASCULAR DISEASE; STENT;

EID: 10744232729     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajkd.2003.06.004     Document Type: Article

References (46)

1. Van de Ven PJ, Kaatee R, Beutler JJ, et al: Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: Randomized trial. Lancet 353:282-286, 1999
2. Harden PN, MacLeod MJ, Rodger RSC, et al: Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 349:1133-1136, 1997
3. Watson PS, Hadjipetrou P, Cox SV, et al: Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 102:1671-1677, 2000
4. Leertouwer TC, Derkx FH, Pattynama PM, et al: Functional effects of renal artery stent placement on treated and contralateral kidneys. Kidney Int 62:574-579, 2002
5. Sheps SG, Osmundson PJ, Hunt JC, et al: Hypertension and renal artery stenosis: Serial observations on 54 patients treated medically. Clin Pharmacol Ther 6:700-709, 1965
6. Wollenweber J, Sheps S, Davis G: Clinical course of atherosclerotic renovascular disease. Am J Cardiol 21:60-71, 1968
7. Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P: Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 17:1743-1750, 1999
8. Dorros G, Jaff M, Mathiak L, et al: Four year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 98:642-647, 1998
9. Dorros G, Jaff M, Mathiak L, He T: Multicenter Palmaz stent renal artery stenosis revascularization registry report: Four-year follow-up of 1,058 successful patients. Catheter Cardiovasc Interv 5:182-188, 2002
10. Muray S, Martin M, Amoedo ML, et al: Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis 39:60-66, 2002
11. Wright JR, Shurrab AE, Cheung C, et al: A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis 39:1153-1161, 2002
12. Chabova V, Schirger A, Stanson AW, et al: Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc 75:437-444, 2000
13. Conlon P, Athirakul D, Kovalik E, et al: Survival in renal vascular disease. J Am Soc Nephrol 9:252-256, 1998
14. Rigatto C, Parfrey P, Foley R, et al: Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 13:1084-1090, 2002
15. Muntner P, He J, Hamm L, et al: Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13:745-753, 2002
16. Akers W, Cross A, Speth R, et al: Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy. Am J Physiol Heart Circ Physiol 279:H2797-H2806, 2000
17. Wolf G: Angiotensin II as a mediator of tubulointerstitial injury. Nephrol Dial Transplant 15:S61-S63, 2000 (suppl 6)
18. Kelly R, O'Hara D, Mitch W, et al: Endogenous digitalis-like factors in hypertension and renal insufficiency. Kidney Int 30:723-729, 1986
19. Losito A, Fagugli RM, Zampi I, et al: Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens 9:1062-1067, 1996
20. Uehata A, Matsuguchi T, Bittl JA, et al: Accuracy of electronic digital calipers compared with quantitative angiography in measuring coronary arterial diameter. Circulation 88:1724-1729, 1993
21. Burket MW, Cooper CJ, Kennedy DJ, et al: Renal artery angioplasty and stent placement: Predictors of a favorable outcome. Am Heart J 139:64-71, 2000
22. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157:2413-2446, 1997
23. Cockroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
24. Wright JT Jr, Bakris G, Greene T, et al: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 20:2421-2431, 2002
25. Franklin SS, Smith RD: Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension. Am J Med 79:14-23, 1985
26. Parfrey PS: Is renal insufficiency an atherogenic state? Reflections on prevalence, incidence, and risk. Am J Kidney Dis 37:154-156, 2001
27. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137:555-562, 2002
28. Wright RS, Reeder GS, Herzog CA, et al: Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 137:563-570, 2002
29. Holland D, Lam M: Predictors of hospitalization and death among pre-dialysis patients: A retrospective cohort study. Nephrol Dial Transplant 15:650-658, 2000
30. Mann JFE, Gerstein HC, Pogue J, et al: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134:629-636, 2001
31. Connolly JO, Higgins RM, Walters HL, et al: Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. QJM 87:413-421, 1994
32. Hallett J, Textor S, Kos P, et al: Advanced renovascular hypertension and renal insufficiency: Trends in medical comorbidity and surgical approach from 1970 to 1993. J Vasc Surg 21:750-760, 1995
33. Jean W, Al-Bitar I, Zwicke D, et al: High incidence of renal artery stenosis in patients with coronary artery disease. Catheter Cardiovasc Diagn 32:8-10, 1994
34. Crowley J, Santos R, Peter R, et al: Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 136:913-918, 1998
35. Uzu T, Inoue T, Fuji T, et al: Prevalence and predictors of renal artery stenosis in patients with myocardial infraction. Am J Kidney Dis 29:733-738, 1997
36. Kudora S, Nishida N, Uzu T, et al: Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke 31:61-65, 2000
37. Miralles M, Corominas A, Cotillas J, et al: Screening for carotid and renal artery stenosis in patients with aortoiliac disease. Ann Vasc Surg 12:17-22, 1998
38. Zierler R, Bergelin R, Polissar N, et al: Carotid and lower extremity arterial disease in patients with renal artery atherosclerosis. Arch Intern Med 158:761-767, 1998
39. Rossi G, Rossi A, Zanin L, et al: Excess prevalence of extracranial carotid artery lesions in renovascular hypertension. Am J Hypertens 5:8-15, 1992
40. Louie J, Isaacson J, Zierler E, et al: Prevalence of carotid and lower extremity arterial disease in patients with renal artery stenosis. Am J Hypertens 7:436-439, 1994
41. O'neil EA, Hansen KJ, Canzanello VJ, et al: Prevalence of ischemic nephropathy in patients with renal insufficiency. Am Surg 58:485-490, 1992
42. Mailloux L, Napolitano B, Bellucci A, et al: Renal vascular disease causing end-stage renal disease, incidence, clinical correlates and outcomes: A 20-year clinical experience. Am J Kidney Dis 24:622-629, 1994
43. Scoble J, Sweny P, Stansby G, Hamilton G: Patients with atherosclerotic renovascular disease presenting to a renal unit: An audit of outcome. Postgrad Med J 69:461-465, 1993
44. Babooloal K, Evans C, Moore R: Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis 31:971-977, 1998
45. Herzog C, Ma J, Collins A: Poor long-term survival after acute myocardial infarction in patients on long-term dialysis. N Engl J Med 339:799-805, 1998
46. Best PJ, Lennon R, Ting HH, et al: The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39:1113-1119, 2002